Recent News

• 04.30.2026 - Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
• 04.24.2026 - Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
• 04.23.2026 - Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
• 04.09.2026 - Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
• 03.26.2026 - Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Recent Filings

• 04.24.2026 - 8-K Current report
• 04.24.2026 - 3/A Initial statement of beneficial ownership of securities
• 04.24.2026 - EX-99.1 EX-99.1
• 04.23.2026 - EX-99.1 EX-99.1
• 04.23.2026 - 8-K Current report
• 04.23.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.20.2026 - PRE 14A Other preliminary proxy statements
• 04.13.2026 - 3 Initial statement of beneficial ownership of securities
• 04.03.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 04.03.2026 - S-8 Securities to be offered to employees in employee benefit plans